US 8940896
Tetra-cyclic carboline derivatives useful in the inhibition of angiogenesis
granted A61KA61K31/4166A61P
Quick answer
US patent 8940896 (Tetra-cyclic carboline derivatives useful in the inhibition of angiogenesis) held by PTC THERAPEUTICS, INC. expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/4166, A61P, A61P17/00, A61P17/06